Human normal immunoglobulin
Pharmaceutical forms
Intramuscular administration
Country lists
ATC N/A
Composition 16% protein solution
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
11.2. Plasma fractions for specific use
  • Others observations:
    Indicated for primary immune deficiency.
PAHO Strategic Fund Medicine List
4.1. Plasma fractions for specific use
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Intravenous administration
Country lists
ATC N/A
Composition 5% protein solution
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
11.2. Plasma fractions for specific use
  • Others observations:
    Indicated for primary immune deficiency and Kawasaki disease.
PAHO Strategic Fund Medicine List
4.1. Plasma fractions for specific use
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Bolivia
LINAME 2011 - 2013
  • No observations
Cuba
19.2 Sueros e inmunoglobulinas
  • No observations
Intravenous administration
Country lists
ATC N/A
Composition 10% protein solution
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
11.2. Plasma fractions for specific use
  • Others observations:
    Indicated for primary immune deficiency and Kawasaki disease.
PAHO Strategic Fund Medicine List
4.1. Plasma fractions for specific use
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Subcutaneous administration
Country lists
ATC N/A
Composition 15% protein solution
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
11.2. Plasma fractions for specific use
  • Others observations:
    Indicated for primary immune deficiency.
Subcutaneous administration
Country lists
ATC N/A
Composition 16% protein solution
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
11.2. Plasma fractions for specific use
  • Others observations:
    Indicated for primary immune deficiency.
Ecuador
Essential Medicines List - Ecuador
  • No observations
Intramuscular administration
Country lists
ATC N/A
Composition 10% protein solution in 2-mL vial
Observations for this pharmaceutical form can be found on the lists:
Cuba
19.2 Sueros e inmunoglobulinas
  • No observations